About Nanoleq
Nanoleq is a company based in Zurich (Switzerland) founded in 2017 was acquired by Myant in November 2024. Nanoleq has raised $13.57 million across 4 funding rounds from investors including Zurcher Kantonalbank, EIT Health and European Union. Nanoleq offers products and services including ElectroSkin, ECG Kit, PhantomTape, and Heart Rate Monitoring Bundle. Nanoleq operates in a competitive market with competitors including Ultrahuman, Oura, Biotricity, Masimo and BioIntelliSense, among others.
- Headquarter Zurich, Switzerland
-
Sectors
RetailTechnology Healthcare Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nanoleq Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.57 M (USD)
in 4 rounds
-
Latest Funding Round
$12.46 M (USD), Series A
Dec 15, 2021
-
Investors
Zurcher Kantonalbank
& 8 more
-
Employee Count
Not available
-
Acquired by
Myant
(Nov 15, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nanoleq
Nanoleq offers a comprehensive portfolio of products and services, including ElectroSkin, ECG Kit, PhantomTape, and Heart Rate Monitoring Bundle.
Electrodes for smart textiles in health monitoring applications.
Kit for electrocardiogram signal monitoring in wearables.
Tape for bio-signal tracking in smart textiles.
Bundle for heart monitoring via smart textiles.
People of Nanoleq
Unlock access to complete
Unlock access to complete
Funding Insights of Nanoleq
Nanoleq has successfully raised a total of $13.57M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $12.46 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nanoleq
Nanoleq has secured backing from 9 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Zurcher Kantonalbank, EIT Health and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed-stage to series A investments are targeted by Capnamic Ventures.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on science and tech-driven startups
|
Locked | Locked | Locked | |
|
University backed startup accelerator
|
Locked | Locked | Locked |
Investor details for Nanoleq
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nanoleq
Investment portfolio details for Nanoleq
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nanoleq
Detailed financials for Nanoleq
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nanoleq Comparisons
Peer comparison for Nanoleq
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nanoleq
Nanoleq operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ultrahuman, Oura, Biotricity, Masimo and BioIntelliSense, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Metabolic health is tracked via devices and fitness platforms.
|
|
| Locked | Locked | Locked |
Health-tracking smart rings and biosensors are developed for biometric monitoring.
|
|
| Locked | Locked | Locked |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
|
| Locked | Locked | Locked |
Provider of wide range of devices to monitor health parameters
|
|
| Locked | Locked | Locked |
Vital signs are monitored via a single-use patch and platform.
|
Detailed competitors of Nanoleq
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nanoleq
Complete news archive for Nanoleq
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nanoleq
Nanoleq was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Nanoleq is headquartered in Zurich, Switzerland.
Nanoleq is a funded company, having raised a total of $13.57M across 4 funding rounds to date.
Nanoleq was founded in 2017 in Zurich, Switzerland, within the health technology sector. Smart textiles are developed for remote monitoring of patient health. Medical wear is offered, integrating sensors into clothing by which vital signs can be tracked precisely. Operations emphasize decentralization of healthcare systems, with tools supplied for individual self-monitoring of health metrics.
Nanoleq's top competitors include Ultrahuman, Oura and Biotricity.
Nanoleq offers ElectroSkin, ECG Kit, PhantomTape, and Heart Rate Monitoring Bundle.
Nanoleq has 9 investors. Key investors include Zurcher Kantonalbank, EIT Health, European Union, Myant, and Capnamic Ventures.